Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens

Laboratory Investigation

Volumn 74, Issue 5, 1996, Pages 861-870

  Imamura, Takahisa ^a   Dubin, Adam ^b   Moore, William ^c   Tanaka, Richard ^c   Travis, James ^d  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Arris Pharmaceutical Corporation   (United States)

^d University of Georgia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; KININOGEN; PREKALLIKREIN; TRYPTASE;

ARTICLE; BLOOD VESSEL PERMEABILITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME PURIFICATION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INCUBATION TIME; MAST CELL; PRIORITY JOURNAL;

ANIMALS; BRADYKININ; CAPILLARY PERMEABILITY; CHYMASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; INFLAMMATION MEDIATORS; KININOGENS; PREKALLIKREIN; SERINE ENDOPEPTIDASES; TIME FACTORS; TRYPTASES;

EID: 0029964503     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Alter SC, Kramps JA, Janoff A, and Schwartz LB (1990). Interaction of human mast cell tryptase with biological protease inhibitors. Arch Biochem Biophys 276:26-31.
2. Alter SC, Lammle B, Griffin JH, and Schwartz LB (1988). Tryptase from human mast cells does not activate purified human Hageman factor. Clin Allergy 18:151-156.
3. Alter SC, Metcalfe DD, Bradford TR, and Schwartz LB (1987). Regulation of human mast cell tryptase: Effect of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J 248:821-827.
4. Baraniuk JN, Lundgren JD, Mizoguchi H, Peden D, Gawin A, Merida M, Shelhamer JH, and Kaliner MA (1990). Bradykinin and respiratory mucous membranes: Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis 141:706-714.
5. Baraniuk JN, Silver PB, Kaliner MA, and Barnes PJ (1994). Perennial rhinitis subjects have altered vascular, glandular and neural responses to bradykinin nasal provocation. Int Arch Allergy Immunol 103:202-208.
6. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, and Proud D (1986). Plasma kallikrein during experimentally induced allergic rhinitis: Role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol 137:977-982.
7. Cochrane DE, Carraway RE, Feldberg RS, Boucher W, and Gelfand JM (1993). Stimulated rat mast cells generate histamine-releasing peptide from albumin. Peptides 14:117-123.
8. Cochrane CG and Griffin JH (1982). The biochemistry and pathophysiology of the contact system of plasma. Adv Immunol 33:241-306.
9. Cool DE, Edgell C-JS, Louie GV, Zoller MJ, Brayer GD, and MacGillivray RTA (1985). Characterization of human blood coagulation factor XII cDNA: Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. J Biol Chem 260:13666-13676.
10. Erdös EG and Yang HYT (1970). Kininases. In: Erdös EG, editor. Handbook of experimental pharmacology: Bradykinin, kallidin and kallikrein, vol. 25. Berlin: Springer-Verlag, 289-323.
11. Fuller RW, Dixon CMS, Cuss FMC, and Barnes PJ (1987). Bradykinin-induced bronchoconstriction in humans: Mode of action. Am Rev Respir Dis 135:176-180.
12. Garcia-Leme J (1978). Bradykinin system. In: Vane JR and Ferreira SH, editors. Handbook of experimental pharmacology: Inflammation, vol. 50. Berlin: Springer-Verlag, 464-522.
13. Gordon JR and Galli SJ (1990). Mast cells as a source of both preformed and immunologically inducible TNF-α/cahectin. Nature 346:274-276.
14. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, and Ramamurthy NS (1989). Synovial procollagenase activation by human mast cell tryptase: Dependence upon matrix metalloproteinase 3 activation. J Clin Invest 84:1657-1662.
15. Harvima IT, Harvima RJ, Penttilä IM, Eloranta TO, Horsmanheimo M, and Fräki JE (1989). Effect of human mast cell tryptase on human plasma proenzymes. Int Arch Allergy Appl Immunol 90:104-108.
16. Imamura T, Pike RN, Potempa J, and Travis J (1994). Pathogenesis of periodontitis: A major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest 94:361-367.
17. Imamura T, Yamamoto T, and Kambara T (1984). Guinea pig plasma kallikrein as a vascular permeability enhancement factor: Its dependence on kinin generation and regulation mechanisms in vivo. Am J Pathol 115:92-101.
18. Ipsen H, Klysner S, Larsen JN, Lowenstein H, Matthiesen F, Schou C, and Sparholt SH (1993). Allergic extracts. In Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, and Busse WW, editors. Allergy. St. Louis: Mosby, 529-553.
19. Kaplan A and Silverberg M (1987). The coagulation-kinin pathway of human plasma. Blood 70:1-15.
20. Lee PY and Pearce FL (1990). Histamine secretion from mast cells stimulated with bradykinin. Agents Actions 30:67-69.
21. Maier M, Spragg J, and Schwartz LB (1983). Inactivation of human high molecular weight kininogen by mast cell tryptase. J Immunol 130:2352-2356.
22. Marceau F, Lussier A, Regoli D, and Giroud JP (1983). Pharmacology of kinins: Their relevance to tissue injury and inflammation. Gen Pharmacol 14:209-229.
23. Maruo K, Akaike T, Inada Y, Ohkubo I, Ono T, and Maeda H (1993). Effect of microbial and mite proteases on low and high molecular weight kininogens: Generation of kinin and inactivation of thiol protease inhibitory activity. J Biol Chem 268:17711-17715.
24. Meier HL, Kaplan AP, Lichtenstein LM, Revak S, Cochrane CG, and Newball HH (1983). Anaphylactic release of a prekallikrein activator from human lung in vitro. J Clin Invest 72:574-581.
25. Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, and Austen KF (1979). Isolation and characterization of heparin from human lung. J Clin Invest 64:1537-1543.
26. Mikhail GR and Miller-Milinska A (1964). Mast cell population in human skin. J Invest Dermatol 43:249-254.
27. Müller-Ester W (1986). Kininogens. In: Bergmeyer HU, Bergmeyer J, and Graßl M, editors. Methods of enzymatic analysis: Proteins and peptides, vol. 9, ed. 3. Weinheim, Germany: VCH, 304-316.
28. Olson ST, Sheffer R, and Francis AM (1993). High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: Role for antithrombin in the regulation of kallikrein. Biochemistry 32:12136-12147.
29. Pixley RA, Cassello A, De La Cadena RA, Kaufman N, and Colman RW (1991). Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost 66:540-547.
30. Proud D, Baily GS, Naclerio RM, Retnolds CJ, Cruz AA, Eggleston PA, Lichtenstein LM, and Togias AG (1992). Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol 89:1098-1110.
31. Proud D, MacGlashan DW Jr, Newball HH, Schulman ES, Lichtenstein LM (1985). Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am J Respir Dis 132:405-408.
32. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, and Naclerio RM (1988a). Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 137:613-616.
33. Proud D, Siekierski ES, and Bailey GS (1988b). Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol 37:1473-1480.
34. Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, and Lichtenstein LM (1990). Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 85:896-905.
35. Proud D, Togias A, Naclerio RM, and Crush SA (1983). Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 72:1678-1685.
36. Salvemini D, Masini E, Anggard E, Mannaioni PF, and Vane J (1990). Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: Stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem Biophys Res Commun 169:596-601.
37. Schechter NM, Eng GY, and McCaslin DR (1993). Human skin tryptase: Kinetic characterization of its spontaneous inactivation. Biochemistry 32:2617-1625.
38. Schwartz BL and Bradford TR (1986). Regulation of tryptase from human mast cells by heparin: Stabilization of the active tetramer. J Biol Chem 261:7372-7379.
39. Schwartz LB, Bradford TR, and Griffin JH (1985b). The effect of tryptase from human mast cells on human prekallikrein. Biochem Biophys Res Commun 129:76-81.
40. Schwartz LB, Bradford TR, Littman BH, and Wintroub BU (1985a). The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135:2762-2767.
41. Schwartz LB, Irani AM, Roller K, Castells MC, and Schechter NM. (1987b). Quantitation of histamine, tryptase and chymase dispersed human T and TC mast cells. J Immunol 138:2611-2615.
42. Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, and Austen KF (1983). Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 130: 1891-1895.
43. Schwartz LB, Lewis RA, and Austen KF (1981a). Tryptase from human pulmonary mast cells: Purification and characterization. J Biol Chem 256:11939-11943.
44. Schwartz LB, Lewis RA, Seldin D, and Austen KF (1981b). Acid hydrases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol 126:1290-1294.
45. Schwartz LB, Maier M, and Spragg J (1986). Interaction of human low molecular weight kininogen with human mast cell tryptase. Adv Exp Med Biol 198:105-111.
46. Schwartz LB, Metcalfe DD, Miller JS, Earl H, and Sullivan T (1987a). Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622-1626.
47. Schwartz LB, Yunginger JW, Miller JS, Bokhari R, and Dull D (1989). The time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551-1555.
48. Sekizawa K, Caughey GH, Lazarus SC, Gold WM, and Nadel JA (1989). Mast cell tryptase causes airway smooth muscle hyper-responsiveness in dogs. J Clin Invest 83:175-179.
49. Shalit M, Schwartz LB, Von Allmen C, Atkins PC, Lavker RM, and Zweiman B (1990). Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 86:117-125.
50. Smith TJ, Hougland HW, and Johnson DA (1984). Human lung tryptase: Purification and characterization. J Biol Chem 259:11046-11051.
51. Svensson C, Andersson M, Persson CGA, Venge P, Alkner U, and Pipkorn U (1990). Albumin, bradykinin, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 85:823-833.
52. Takagaki Y, Kitamura N, and Nakanishi S (1985). Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens: Primary structures of two human prekininogens. J Biol Chem 260: 8601-8609.
53. Udaka K, Takeuchi Y, and Movat HZ (1970). Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med 133:1384-1387.
54. Van der Linden PG, Hack CE, Eerenberg AJM, Struyvenberg A, and Van der Zwan JK (1993). Activation of the contact system in insect-sting anaphylaxis: Association with the development of angioedema and shock. Blood 82:1732-1739.
55. Van der Linden PG, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, and Van der Zwan JK (1992). Insect-sting challenge in 138 patients: Relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 90:110-118.
56. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, and Caughey GH (1990). Human mast cell tryptase: Multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci USA 87:3811-3815.
57. Varonier HS and Panzani R (1968). The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children. Int Arch Allergy Appl Immunol 34:293-296.
58. Walls AF, Bennett AR, Sueiras-Dias J, and Olsson H (1992). The kininogenase activity of human mast cell tryptase. Biochem Soc Trans 22:260S.
59. Wenzel SA, Fowler AA III, and Schwartz LB (1988). Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 137: 1002-1008.
60. Wuepper KD and Cochrane CG (1972). Plasma prekallikrein: Isolation, characterization, and mechanism of activation. J Exp Med 135:1-20.
61. Yang HYT and Erdös EG (1967). Second kininase in human blood plasma. Nature 215:1402-1403.
62. Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, Biedrzycki L, Sweeney KG, Sturner WQ, and Schwartz LB (1991). Laboratory investigation of deaths due to anaphylaxis. J Forens Sci 36:857-865.